About
Our Company
Leadership
Corporate Responsibility
Chevron right
Corporate Sustainability
Chevron right
Sustainability Approach
Access to Medicines
Sustainability Disclosures
Ethics & Disclosures
Chevron right
Ethics
Transparency Disclosures
Positions
Corporate Giving
Corporate Governance
Chevron right
Governance Strategy
Governance Structure
Charters and Reports
Science
Areas of Focus
Research and Development
Pipeline
Products
Chevron right
Our Products
Manufacturing
Suppliers
Clinical Trials
Our Impact
Our Stories
Newsroom
Press Releases
Statements
Media Resources
Investors
Overview
Financial Results
Investor Events
Investor Contact
Careers
About
Our Company
Leadership
Corporate Responsibility
Corporate Sustainability
Sustainability Approach
Access to Medicines
Sustainability Disclosures
Ethics & Disclosures
Ethics
Transparency Disclosures
Positions
Corporate Giving
Corporate Governance
Governance Strategy
Governance Structure
Charters and Reports
Science
Areas of Focus
Research and Development
Pipeline
Products
Our Products
Manufacturing
Suppliers
Clinical Trials
Our Impact
Our Stories
Newsroom
Press Releases
Statements
Media Resources
Investors
Overview
Financial Results
Investor Events
Investor Contact
Careers
Search...
Open Location Finder
GLOBAL
VerticalLine
EN
Search
Statement Re: Abbvie’S Intention To Reconsider Recommendation
Statement Re: Abbvie’S Intention To Reconsider Recommendation
Calendar
October 15, 2014
Share
Share
Download this article
Back to top
